Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone.
Geffen
D B
DB
Department of Oncology, Soroka Medical Center, Beer Sheva, Israel. dgeffen@bgumail.bgu.ac.il
Horowitz
J
J
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003286:Contracture / Q000209:etiology; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D004347:Drug Interactions; D004487:Edema / Q000139:chemically induced*; D005938:Glucocorticoids / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000556:secondary; D011241:Prednisone / Q000494:pharmacology* / Q000627:therapeutic use; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D005938:Glucocorticoids; D003841:Deoxycytidine; D012264:Ribonucleotide Reductases; D011241:Prednisone; D000093542:Gemcitabine